Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Other Operating Expenses (2021 - 2025)

Coeptis Therapeutics Holdings has reported Other Operating Expenses over the past 5 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $2.5 million for Q4 2025, up 71.01% from a year ago — trailing twelve months through Dec 2025 was $12.0 million (up 76.35% YoY), and the annual figure for FY2025 was $11.8 million, up 102.39%.
  • Other Operating Expenses for Q4 2025 was $2.5 million at Coeptis Therapeutics Holdings, up from $1.9 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for COEPW hit a ceiling of $30.9 million in Q4 2022 and a floor of $59282.0 in Q3 2022.
  • Median Other Operating Expenses over the past 5 years was $2.0 million (2023), compared with a mean of $4.1 million.
  • Peak annual rise in Other Operating Expenses hit 4345.98% in 2023, while the deepest fall reached 93.49% in 2023.
  • Coeptis Therapeutics Holdings' Other Operating Expenses stood at $13.7 million in 2021, then skyrocketed by 125.45% to $30.9 million in 2022, then tumbled by 93.49% to $2.0 million in 2023, then fell by 27.64% to $1.5 million in 2024, then soared by 71.01% to $2.5 million in 2025.
  • The last three reported values for Other Operating Expenses were $2.5 million (Q4 2025), $1.9 million (Q3 2025), and $3.9 million (Q2 2025) per Business Quant data.